Clinical Trials Browser

Phase 2 × Neoplasms, Squamous Cell × Imatinib Mesylate × Clear all

NCT00485485 2012-08-07

Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer

Phase 2 Completed

7 enrolled 7 charts

Head and Neck Neoplasms, Neoplasms, Squamous Cell